Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach: The Real-life Effectiveness of Omalizumab Therapy (REALITY) study

The evidence on long-term real-life response measures to omalizumab therapy in moderate to severe asthma is limited. A universal assessment tool is needed to adequately evaluate response to omalizumab in these patients. To design a multimodular response assessment tool and use it to measure and defi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of allergy, asthma, & immunology asthma, & immunology, 2019-11, Vol.123 (5), p.476-482.e1
Hauptverfasser:	Singh, Harjinder, Peters, Jay I, Kaur, Yogeet, Maselli, Diego J, Diaz, Joseph D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anti-Allergic Agents - therapeutic use Anti-Asthmatic Agents - therapeutic use Asthma - blood Asthma - drug therapy Child Child, Preschool Emergency Service, Hospital - statistics & numerical data Female Hospitalization - statistics & numerical data Humans Immunoglobulin E - blood Male Medication Adherence Middle Aged Omalizumab - therapeutic use Retrospective Studies Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!